Decreased B cell transcriptional signatures in acute HCV infection. by Brad R. Rosenberg (5754194)

FGF2 decreases the thickness of early born tectal layers. by Luke D. McGowan (483282)

“…<p>By ED12, birds treated with FGF2 showed a 50% decrease in the radial thickness of the deep layers in the lateral tectum compared to controls (A, B, D). …”

Discrimination performance deteriorated as the safe-to-conditioned ΔF decreased. by Chi Chen (67021)

PHA decreased pro-inflammatory microglia/macrophages (M1). by Zhenying Han (621634)

Decreased SPTAN1 expression leads to reduced cell migration. by Anne Ackermann (6443975)

Caspase-1 activity in cell-extract decreases over time. by Obada R. Shamaa (830382)

Adoptive transfer of mature NK cells decreases the incidence of BA and improves survival, and the level of VP4 in cholangiocytes and the incidence of BA are decreased as the age of... by Yinrong Qiu (345978)

Adenosine inhibits AMPA EPSCs by decreasing presynaptic glutamate release. by Shouping Wang (402959)

mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

“…(<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”

The %change in GABA level had a trend correlation with MEP amplitude in the left sensorimotor area (R = −0.43002, R2 = 0.1849, t = 1.844717, p = 0.082575). by Hiroyuki Matsuta (13250169)

Relative decrease in <i>G</i>′ at <i>f</i>_s = 10 Hz due to 25-fold decrease of various stiffnesses at different prestrains. by Taeyoon Kim (122486)

Melting points of HNL1 (A & B) and <i>Hb</i>HNL (C & D). by Bryan J. Jones (7354394)

“…<p>Melting points were measured by decreases in fluorescence intensity (A & C) and by decreases in fluorescence lifetime (B & D). …”

Methotrexate susceptibility of <i>L</i>. <i>major</i> Friedlin mutants derived from a Mut-seq screen. by Sophia Bigot (16469992)

Affinity analysis results (with a confidence level above 50%). by Marta R. Jabłońska (8491404)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 ^a indicates ≥1.50 SD (17.9) from the mean (32.9... by Luke R. Cavanah (19022435)

Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 ^a indicates ≥1.50 SD (20.2) from the mean (36.... by Luke R. Cavanah (19022435)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 ^a indicates ≥1.50 SD (18.0) from the mean (33.1... by Luke R. Cavanah (19022435)

Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 ^a indicates ≥1.50 SD (16.8) from the mean (31.0... by Luke R. Cavanah (19022435)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 ^a indicates ≥1.50 SD (16.0) from the mean (29.9... by Luke R. Cavanah (19022435)

Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 ^a indicates ≥1.50 SD (19.2) from the mean (34.... by Luke R. Cavanah (19022435)